Immix Biopharma (IMMX) Cash from Financing Activities (2021 - 2026)
Immix Biopharma's Cash from Financing Activities came in at $155.28 million for Q2 2026.
Powered by 
Analysis
Immix Biopharma (IMMX) Cash from Financing Activities (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Immix Biopharma reported Cash from Financing Activities of $261.52 million; for FY2025, it came in at $107.39 million, up 573.3% from FY2024.
- Cash from Financing Activities has increased in each of the last three years, with a four-year compound annual growth rate of 54.5% (FY2021 to FY2025).
- Going back by year, Cash from Financing Activities was $15.95 million in FY2024 (+3.1%), $15.46 million in FY2023 (+378.4%), $3.23 million in FY2022 (-82.9%) and $18.85 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Cash from Financing Activities in data going back to Q1 2021.
- Business Quant data shows IMMX's Cash from Financing Activities at -$37,561 (Q1 2026), $95.67 million (Q4 2025) and $10.61 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Immix Biopharma | 743.97 Mn | 743.97 Mn | - | 155.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 155.28 Mn |
| Mar 31, 2026 | -37,561.00 |
| Dec 31, 2025 | 95.67 Mn |
| Sep 30, 2025 | 10.61 Mn |
| Mar 31, 2024 | 15.95 Mn |
| Dec 31, 2023 | 586,692.00 |
| Sep 30, 2023 | 10.07 Mn |
| Jun 30, 2023 | 4.69 Mn |
| Mar 31, 2023 | 118,916.00 |
| Dec 31, 2022 | 424,276.00 |
| Jun 30, 2022 | -105,963.00 |
| Mar 31, 2022 | 2.91 Mn |
| Dec 31, 2021 | 18.72 Mn |
| Sep 30, 2021 | -18,349.00 |
| Jun 30, 2021 | 82,327.00 |
| Mar 31, 2021 | 65,000.00 |
API Access
Immix Biopharma Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IMMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "IMMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IMMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();